Generation of an induced pluripotent stem cell line (DHMCi006-A) from a patient with autosomal recessive polycystic kidney disease (ARPKD) carrying a compound heterozygous missense mutation in the fibrocystin encoding PKHD1 gene
Summary
Mutations in the PKHD1 gene, encoding for the ciliary protein fibrocystin, play a major role in the cystogenesis in autosomal recessive polycystic kidney disease (ARPKD), a severe pediatric kidney disorder. Peripheral blood mononuclear cells (PBMCs) from a female patient carrying a compound heterozygous PKHD1 mutation (c.6331A>G(;)7717C>T) were obtained and reprogrammed by viral transduction using the Cytotune®-iPS 2.0 Sendai Reprogramming Kit (Invitrogen). The resulting iPSCs display a normal karyotype, express pluripotency markers, and show the potential for spontaneous differentiation in vitro, offering a useful tool for studying ARPKD pathomechanisms and drug screening. Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
| Authors | Fluhr TL, Tabatabaeifar M, Syring H, Göhring G, Schaefer F, Jung-Klawitter S |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2021 Dec;57:102579 |
| PubMed | 34695767 |
| DOI | 10.1016/j.scr.2021.102579 |